238 Supplementary References to Box 1 Wong CB, Tanaka A, Kuhara T, Xiao JZ. Potential effects of Indole-3-Lactic Acid, a Metabolite of Human Bifidobacteria, on NGF-induced Neurite Outgrowth in PC12 Cells. Microorganisms 2020;8(3):398. doi: 10.3390/microorganisms8030398. Laursen MF, Sakanaka M, von Burg N, Mörbe U, Andersen D, Moll JM, et al. Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut. Nat Microbiol 2021;6(11):1367-1382. doi: 10.1038/s41564-021-00970-4. Ehrlich AM, Pacheco AR, Henrick BM, Taft D, Xu G, Huda MN, et al. Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells. BMC Microbiol 2020;20(1):357. doi: 10.1186/s12866-020-02023-y. Henrick BM, Rodriguez L, Lakshmikanth T, Pou C, Henckel E, Arzoomand A, et al. Bifidobacteria-mediated immune system imprinting early in life. Cell 2021;184(15):3884-3898.e11. doi: 10.1016/j.cell.2021.05.030. Bakos E, Homolya L. Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1). Pflugers Arch 2007;453(5):621-41. doi: 10.1007/s00424-006-0160-8. He SM, Li R, Kanwar JR, Zhou SF. Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1). Curr Med Chem 2011;18(3):439-81. doi: 10.2174/092986711794839197. Yoshii K, Hosomi K, Sawane K, Kunisawa J. Metabolism of Dietary and Microbial Vitamin B Family in the Regulation of Host Immunity. Front Nutr 2019;6:48. doi: 10.3389/fnut.2019.00048. Beedholm-Ebsen R, van de Wetering K, Hardlei T, Nexø E, Borst P, Moestrup SK. Identification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalamin. Blood 2010;115(8):1632-9. doi: 10.1182/blood-2009-07-232587. Lee JH, O’Sullivan DJ. Genomic insights into bifidobacteria. Microbiol Mol Biol Rev 2010;74(3):378-416. doi: 10.1128/MMBR.00004-10. Bantel H, Schmitz ML, Raible A, Gregor M, Schulze-Osthoff K. Critical role of NF-kappaB and stressactivated protein kinases in steroid unresponsiveness. FASEB J 2002;16(13):1832-4. doi: 10.1096/fj.020223fje. Karin M, Chang L. AP-1--glucocorticoid receptor crosstalk taken to a higher level. J Endocrinol 2001;169(3):447-51. doi: 10.1677/joe.0.1690447. Barbian ME, Owens JA, Naudin CR, Denning PW, Patel RM, Jones RM. Butyrate supplementation to pregnant mice elicits cytoprotection against colonic injury in the offspring. Pediatr Res 2021; doi: 10.1038/s41390-021-01767-1. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491(7422):119-24. doi: 10.1038/nature11582. Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 2015;47(9):979-986. doi: 10.1038/ng.3359. Ye BD, McGovern DPB. Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility. Exp Rev Clin Immunol 2016;12(10):1091-107. doi: 10.1080/1744666X.2016.1184972. Di Narzo AF, Peters LA, Argmann C, Stojmirovic A, Perrigoue J, Li K, et al. Blood and Intestine eQTLs from an Anti-TNF-Resistant Crohn’s Disease Cohort Inform IBD Genetic Association Loci. Clin Transl Gastroenterol 2016;7(6):e177. doi: 10.1038/ctg.2016.34. Povoleri GAM, Nova-Lamperti E, Scottà C, Fanelli G, Chen YC, Becker PD, et al. Human retinoic acidregulated CD161+ regulatory T cells support wound repair in intestinal mucosa. Nat Immunol 2018;19(12):1403-1414. doi: 10.1038/s41590-018-0230-z. Chapter 6 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
RkJQdWJsaXNoZXIy MjY0ODMw